Proceedings of the National Academy of Sciences · 2006 · 312 citations · 27 references
MedicineCancer BiologyOncologyCarcinogenesisMolecular OncologyTumor ProgressionCancer ProgressionCancer Stem Cell BiologyCancer Stem CellsProstate CancerProstatic PathologyTumor Suppressor GenesMolecular Initiating EventsMurine ModelsProstate Basal Cell BiologyProstate CarcinogenesisProstate Stem Cell BiologyPten InactivationPten SignalingTumor Initiating Cells
PTEN (phosphatase and tensin homolog deleted on chromosome 10) is a potent tumor suppressor gene frequently mutated in human prostate cancers. Deletion of Pten in a murine model of prostate cancer recapitulates the disease progression seen in humans. Using defined cell lineage markers, we demonstrate that PTEN negatively regulates p63-positive prostatic basal cell proliferation without blocking differentiation. Concomitant with basal cell proliferation is the expansion of a prostate stem/progenitor-like subpopulation as evidenced by the progressive increase of stem cell antigen-1 (Sca-1)- and BCL-2-positive cells. This observation provides strong evidence that basal cell proliferation can be an initiating event for precancerous lesions. Sca-1(+) and BCL-2(+) progenitors may serve as cancer-initiating cells in this model.
27
Robert T. Greenlee, Thomas S. Murray, S. Bolden et al. · CA A Cancer Journal for Clinicians · 2000 · 3.9K citations · Full text
Shunyou Wang, Jing Gao, Qun‐Ying Lei et al. · Cancer Cell · 2003 · 1.1K citations · Full text